24/7 Market News Snapshot 05 June, 2025 – Autonomix Medical, Inc. Common Stock (NASDAQ:AMIX)

June 5, 2025

DENVER, Colo., 05 June, 2025 (www.247marketnews.com) – (NASDAQ:AMIX) are discussed in this article.
Autonomix Medical, Inc. (NASDAQ:AMIX) has recently encountered a significant bearish trend, with its shares trading at $1.525, reflecting a decline of approximately 7.01% from the previous close of $1.640. This downturn suggests heightened selling pressure, evidenced by a trading volume of 2.45 million shares. Technical indicators, including moving averages, indicate a potential downtrend, with resistance levels likely forming around the last closing price. Investors are advised to observe potential support levels below, as further declines could indicate a growing bearish sentiment in the stock.

On a promising note, Autonomix is at a pivotal juncture with the recent approval of its follow-on clinical trial, known as PoC 2, which focuses on expanding its innovative ablation technology to treat visceral cancer pain. This trial is poised to commence patient enrollment in June 2025 and aims to build on the encouraging results from its initial proof-of-concept study that addressed severe pancreatic cancer pain.

The first-phase study demonstrated promising outcomes—including substantial pain relief, reduced opioid dependency, and enhanced quality of life for patients—bolstering confidence in the company’s transvascular energy delivery system. Brad Hauser, CEO of Autonomix, emphasized the importance of this approval, noting that it represents a significant advancement that could enable the company to explore a broader range of visceral cancers associated with pain signals from the Celiac Plexus.

With plans to address various oncological applications, including pancreatic, gall bladder, liver, and bile duct cancers, Autonomix is steadfast in its mission to transform medical care and improve patient outcomes. As the company moves forward, it remains focused on meeting critical unmet medical needs while creating long-term value through its innovative medical solutions.

Related news for (AMIX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.